Search - tctmd.com

Displaying 301 - 320 of 433

Sort: Relevancy | Date

News Industry News

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

October 12, 2015

News Conference News TCT 2015

Absorb BVS Matches Xience V in Chinese Patients

Todd Neale

October 12, 2015

News Conference News TCT 2015

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

October 12, 2015

News Conference News TCT 2015

Novel Devices Present New Treatment Options for STEMI

Yael L. Maxwell

October 11, 2015

News Industry News

Boston Scientific Announces Scheduled Presentations At TCT 2015

October 08, 2015

News Industry News

SurModics Receives FDA IDE Approval for Early Feasibility Study of the SurVeil™ Drug-Coated Balloon

October 06, 2015

News Industry News

Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System

October 05, 2015

News Industry News

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

September 30, 2015

News Daily News

Study Supports Multiarterial CABG for Multivessel CAD

Todd Neale

September 24, 2015

News Industry News

QT Vascular wins CE Mark for drug-coated balloon

September 10, 2015

News Conference News ESC 2015

ABSORB Trials Pit BRS Against Second-Generation DES

Caitlin E. Cox

September 02, 2015

News Industry News

Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study

September 01, 2015

News Daily News

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

Yael L. Maxwell

August 26, 2015

News Daily News

Lower-Profile Graft for TEVAR Demonstrates Safety, Device Success Out to 1 Year

L.A. McKeown

August 10, 2015

News Daily News

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

Yael L. Maxwell

July 31, 2015

News Daily News

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

Yael L. Maxwell

July 29, 2015

News Industry News

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

July 20, 2015

News Daily News

DES, BMS Both Suitable for Treating Patients With SVG Lesions

July 20, 2015

News Industry News

Boston Scientific Initiates Study Evaluating New Fully Resorbable Scaffold Technology

July 20, 2015

News Daily News

High-Sensitivity CRP Predicts Long-term Mortality in Patients Receiving DES

L.A. McKeown

July 20, 2015

Advertisement

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

Absorb BVS Matches Xience V in Chinese Patients

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

Novel Devices Present New Treatment Options for STEMI

Boston Scientific Announces Scheduled Presentations At TCT 2015

SurModics Receives FDA IDE Approval for Early Feasibility Study of the SurVeil™ Drug-Coated Balloon

Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

Study Supports Multiarterial CABG for Multivessel CAD

QT Vascular wins CE Mark for drug-coated balloon

ABSORB Trials Pit BRS Against Second-Generation DES

Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

Lower-Profile Graft for TEVAR Demonstrates Safety, Device Success Out to 1 Year

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

DES, BMS Both Suitable for Treating Patients With SVG Lesions

Boston Scientific Initiates Study Evaluating New Fully Resorbable Scaffold Technology

High-Sensitivity CRP Predicts Long-term Mortality in Patients Receiving DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content